secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protara Therapeutics, Inc. (TARA)
CIK:        0001359931
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001213900-25-121687
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protara closes full underwriters' option, gross proceeds ~$86.3M from offering
------------------------------------------------------------------------------

- Closed full exercise of underwriters' option for 1,956,521 shares at $5.75/share on Dec 15, 2025.
- Combined with Dec 8 firm shares (13,043,479), total gross proceeds expected ~$86.3M.
- Net proceeds to fund clinical development of TARA-002 and other programs.
- Offering made under effective S-3 registration statement (File No. 333-275290).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1359931/000121390025121687/0001213900-25-121687-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1359931/000121390025121687/ea0269478-8k_protara.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-121687

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer